Skip to main content

Carbaglu Side Effects

Generic name: carglumic acid

Medically reviewed by Last updated on Feb 7, 2024.

Note: This document contains side effect information about carglumic acid. Some dosage forms listed on this page may not apply to the brand name Carbaglu.

Applies to carglumic acid: oral tablet for suspension.

Serious side effects of Carbaglu

Along with its needed effects, carglumic acid (the active ingredient contained in Carbaglu) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking carglumic acid:

More common

Less common

Incidence not known

Get emergency help immediately if any of the following symptoms of overdose occur while taking carglumic acid:

Symptoms of overdose

Other side effects of Carbaglu

Some side effects of carglumic acid may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

For Healthcare Professionals

Applies to carglumic acid: oral tablet dispersible.


The more commonly reported adverse reactions have included vomiting, abdominal pain, pyrexia, and infection.[Ref]


Very common (10% or more): Vomiting (26%), abdominal pain (17%), tonsillitis (17%), diarrhea (13%)

Common (1% to 10%): Dysgeusia[Ref]


Common (1% to 10%): Decreased weight, anorexia, hyperglycemia[Ref]


Very common (10% or more): Infections (13%)

Common (1% to 10%): Influenza[Ref]


Very common (10% or more): Anemia (13%), decreased hemoglobin (13%)

Common (1% to 10%): Thrombocytopenia[Ref]

Nervous system

Very common (10% or more): Headache (13%)

Common (1% to 10%): Somnolence[Ref]


Common (1% to 10%): Hyperhidrosis, rash

Postmarketing reports: Pruritus, rash including rash erythematous, rash maculopapular, rash pustular[Ref]


Common (1% to 10%): Increased transaminases


Very common (10% or more): Nasopharyngitis (13%)

Common (1% to 10%): Pneumonia, oxygen saturation decreased


Very common (10% or more): Pyrexia (17%), ear infection (13%)

Common (1% to 10%): Asthenia


Common (1% to 10%): Cardiac murmur

Uncommon (0.1% to 1%): Bradycardia


Postmarketing reports: Mania


1. Cerner Multum, Inc. Australian Product Information.

2. Product Information. Carbaglu (carglumic acid). Accredo Health Group Inc. 2010.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.